Condition
Crohn Disease in Remission
Total Trials
6
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown3
Completed1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04100005Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
NCT06555042Recruiting
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
NCT05463900Unknown
Microbial and Human Determinants of the Onset of IBD Flares
NCT05214430Not ApplicableCompletedPrimary
Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
NCT03172377Phase 4UnknownPrimary
Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients
NCT04321863UnknownPrimary
Stratifying Crohn's Using Biomarker Assessment
Showing all 6 trials